1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Compliance

Another Catheter Class I Recall, This Time For Vascular Solutions

US regulators have announced a second serious recall for a faulty catheter in the past month. The problem with Vascular Solutions’ catheter seems to be similar to Boston Scientific’s recall earlier this month, where a part of the device may break off and get stuck in the patient.

MAPLE GROVE, MN/USA - MARCH 17, 2018: Teleflex and Vascular Solutions corporate building. Teleflex is a provider of specialty medical devices for a range of procedures in critical care and surgery.

The US Food and Drug Administration has announced a high-risk class I recall for Vascular Solutions Inc.’s Langston Dual Lumen Catheter due to concerns that part of the catheter can break off from the device and become lodged in the patient, potentially causing serious harm and even death.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Compliance

More from Policy & Regulation

Global Medtech Guidance Tracker: April 2025

 
• By Vibha Sharma

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. 25 documents have been posted on the tracker since its last update.

South Korea Adds Digital Health Rules To Already Complicated Regulatory Landscape

 
• By Elizabeth Orr

A New South Korean law, the Digital Medical Products Act, enhances regulation for digital health products. Medical devices in the country are categorized both by risk and by similarity to already authorized devices. The approval process may stretch to 515 days for new manufacturers.

Switzerland Investigates Private Sector Assessment of FDA-Approved Medical Devices

 
• By Amanda Maxwell

Its move comes as the Swiss recognize the need to ensure adequate supplies on medical devices in its country.